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Translational relevance 
We used TCGA datasets from Head and Neck Squamous Cell Carcinoma (HNSCC) 
patients and patient-derived tumour sections from Human Papilloma Virus (HPV)-
positive/-negative oropharyngeal HNSCC to clinically validate in vitro data generated 
using primary human foreskin keratinocytes (HFK) expressing the HPV16 E6/E7 
oncogenes. The novel and translational aspects of this study are; 
1. Slug/SNAI2 is the main epithelial-to-mesenchymal transition (EMT)-
activating transcription factor in HNSCC and E6/E7-HFK, 
2. Activation of SRC and downstream targets mediate the Slug/SNAI2-evoked 
EMT, 
3. We show for the first time that a particular p63 isoform, namely, ΔNp63γ is 
necessary and sufficient to activate SRC signalling axis, induce EMT and 
invasion.  
      This manuscript is relevant to those investigating (a) the oncogenic significance of 
p63 transcription factors, (b) the role of upstream pathways in the activation of Slug, 
and (c) the therapeutic potential of SRC inhibitors in clinical trials on epidermal 
growth factor receptor resistant HNSCC patients. 
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Abstract 
Purpose: To investigate the regulation of epithelial-to-mesenchymal transition 
(EMT)  in  Head and Neck Squamous Cell Carcinoma (HNSCC) and its importance 
in tumour invasion. 
Experimental design:  
We use a 3D invasive organotypic raft culture model of human foreskin keratinocytes 
expressing the E6/E7 genes of the Human Papilloma Virus-16,  coupled with 
bioinformatic and immunhistochemical analysis of patient samples to investigate  the 
the role played by EMT in invasion and identify effectors and upstream regulatory 
pathways. 
Results: We identify SNAI2 (Slug) as a critical effector of EMT activated 
downstream of TP63 overexpression in Head and Neck Squamous Cell Carcinoma 
(HNSCC). Splice-form specific depletion and rescue experiments further identify the 
ΔNp63γ isoform as both necessary and sufficient to activate the SRC signalling axis 
and SNAI2-mediated EMT and invasion. Moreover, elevated SRC levels are 
associated with poor outcome in HNSCC patients in the cancer genome atlas dataset. 
Importantly, the effects on EMT and invasions and SNAI2 expression can be reversed 
by genetic or pharmacological inhibition of SRC. 
 Conclusion: Overexpression of ΔNp63γ modulates cell invasion by inducing 
targetable SRC-Slug-evoked EMT in HNSCC, which can be reversed by inhibitors of 
the SRC signalling. 
 
Key words: Human papilloma virus (HPV), keratinocytes, p63, Src, Slug, epithelial-
to-mesenchymal transition (EMT) 
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Introduction 
       Head and Neck Squamous Cell Carcinoma (HNSCC) represents the sixth most 
commonly diagnosed cancer worldwide (>500,000 new cases pa) (1).  The frequency 
of HNSCC is increasing, particularly in a younger age group associated with HPV 
infection, which accounts for 23-60% of cases (2). Currently there are limited options 
for biomarker-guided, molecular-targeted therapies in HNSCC because of a poor 
understanding of the disease at the molecular level. 
 Amplification and overexpression of TP63 occurs independently of TP53 
mutation or HPV infection in the majority of SCCs (3,4), the clinical importance of 
which remains unclear. The TP63 locus is complex and encodes at least six well-
described isoforms that play overlapping but distinct roles in activating or repressing 
target gene expression.  This occurs as a result of utilisation of two alternative 
promotors resulting in TA (transactivation) and ΔN (lacks the TA domain) N-terminal 
isoforms, each of which can be alternatively spliced with C-terminal variants α, β and 
γ (5). Traditionally, elevated expression of the predominant ΔNp63α isoform has been 
assumed to promote SCC growth by opposing activation of canonical TP53/TP73 
regulated cell cycle repressive and pro-apoptotic targets (6,7). Importantly, recent data 
from our group and others indicate that TP63 plays essential TP53-independent roles 
in promoting and maintaining squamous transformation stimulating invasion and 
migration and is paradoxically, necessary to induce differentiation in normal cells (8-
10). Our integrative genome-wide analyses of TP53-TP63 function highlighted the 
extent of the network of genes potentially affected by the TP63-TP53 axis, and the 
importance of up-regulation of TP63 target genes in HNSCC (11,12).  
  Previously, we and others have shown that TP63 is involved in supporting an 
Epithelial-to-Mesenchymal Transition (EMT)-phenotype in normal breast epithelial 
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cells (13,14).  E-cadherin (CDH1), an adherens junction protein and an epithelial 
marker, is essential for knitting the epithelial cells together, and the loss (through 
suppression of CDH1 expression and/or its relocalisation away from cell-cell 
contacts) is critical for the acquisition of EMT (15). This can be mediated through the 
activities of EMT-inducing transcription factors including Twist (TWIST1), Snail 
(SNAI1) and Slug (SNAI2), which are known to directly repress transcription from 
the CDH1 promoter thereby promoting the disassembly of the cell-cell contacts 
(16,17). Vimentin, a hallmark of EMT encoded by the VIM gene, is also 
overexpressed in malignant epithelial breast and vulvar cancers and correlates with 
poor prognosis (18,19). Hence in invasive cancers, several molecular pathways are 
altered to support the upregulation and protein stabilisation of EMT-promoting genes.  
  We recently used a 3D-organotypic model of human foreskin keratinocytes 
(HFK) stably expressing the high-risk HPV-16 E6 and E7 oncoproteins (E6/E7-HFK) 
to identify the non-receptor tyrosine kinase Src, as a TP63 target gene in oro-
pharyngeal cell carcinoma, a subset of HNSCC (8,20,21). Src is a critical regulator of 
cell migration, the upregulation of which has been observed in several cancers 
including HNSCC, where this has a direct correlation with disease progression 
(18,19). Our study elucidated the importance of TP63 in transcriptionally regulating a 
Src-MMP axis that is required for migration and invasion, which could be inhibited 
by TP63 or Src depletion or Src activity inhibition. 
      In this study, we show for the first time that the ΔNp63γ isoform is an 
important factor in regulating EMT through Slug/SNAI2 and SRC and that the EMT 
phenotype and invasion can be reversed by inhibition of SRC activity. 
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Material and methods 
 
Cell culture 
     Primary neonatal HFK expressing an empty vector (pBabe-HFK) or E6/E7-HFK 
were cultured as monolayer to subconfluence in Epilife medium on collagen-I coated 
plates before harvesting mRNA and proteins. A fraction of these cells were seeded on 
Rb-depleted human foreskin fibroblast embedded in collagen-I plugs to establish 3D-
organotypic rafts for studying invasion (8,22). After 14 days of incubation in E-
medium, the rafts were sliced, embedded in paraffin, sectioned and used for 
immunofluorescence and H&E stains. The invasive incidents were quantified using 
H&E stained sections and represented as number of invasions/cm recorded from three 
independent experiments. 
Retroviral constructs and stable knockdown 
     The stable knockdowns of non-specific (scram) or p63 isoforms (UTR, DBD) in 
E6/E7-HFK were established by shRNA molecules (9) ligated in the pSuper-retro-neo 
constructs before their transfection in the 293T cells. The retroviruses generated using 
the phoenix system were used to infect HFK and GFP-tagged constructs acted as 
positive controls for measuring infection efficiency (22). 
Adenovirus-mediated overexpression 
     To generate shRNA resistance ΔNp63α/β/γ isoforms, 5µg of entry vector 
pENTR11(Life technologies) carrying the gene of interest (GFP or ΔNp63α/β/γ) were 
subjected to site directed mutagenesis for four point mutations as previously described 
(13), and were sequence verified before recombination with the adenoviral 
pAd/CMV/V5-DEST Gateway vector (Life technologies, UK) using Gateway-LR 
Clonase-II enzyme mix (Life technologies) according to the manufacturer’s 
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guidelines. Similarly, the constitutively active Src (Src-531) construct was generated 
by site-directed mutagenesis (8) before recombination with adenoviral vector. The 
recombined vector was transfected in 293T cells before generation, purification and 
titration of adenovirus as previously described (23). 
Transient knockdown 
     Transient gene/protein knockdowns in E6/E7-HFK were established by 
transfection with 50 nM of non-specific (scram) or specific siRNA molecules 
targeting Slug (mol-1:5’-CAAACGACTTTGCAACTCC-3’, mol-2:5’-
CCTCTTGGCATACTCCTCT-3’) (24), Src and p63 (UTR, Pan) as previously 
described (8).   
RNA extraction and quantitative real-time polymerase chain reaction (RT-PCR) 
     The total RNA was harvested from HFK samples using Trizol reagent (Roche, 
USA) according to the manufacturer’s instructions. After measuring the purity, 1µg 
RNA was used to synthesise cDNA by single-strand cDNA synthesis kit (Roche, 
USA) followed by PCR amplification to study the fold difference in mRNA levels 
after normalisation against reference gene RPLP0 as previously described (12). 
Western blotting 
     50µg of whole cell lysates were resolved on 10% SDS-PAGE gels before transfer 
of proteins onto nitrocellulose membrane which was followed by blocking in 5% milk 
and incubation with primary antibodies against human E-cadherin, N-cadherin, 
Fibronectin (BD biosciences), Slug, Snail, vimentin, Src, Src-pY416, AKT-pS473, AKT 
(Cell signalling), p63 (Abcam), Twist, ZEB1, ZEB2 (Santa Cruz Biotech) GAPDH 
and β-actin (Sigma-Aldrich). Using HRP-tagged species specific-secondary 
antibodies, the differential protein expressions were visualised by chemiluminescence 
detection. 
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Immunofluorescence  
     The cellular localisation of proteins was studied by fixing monolayer of HFK, 
which was followed by permeabilisation and exposure to primary and species-specific 
Alexa-fluor-488/594-tagged secondary antibodies (Life technologies). The proteins 
were visualised through 20x and 60x magnification by confocal microscopy. The 
cellular localisation of proteins in HNSCC sections or on 3D-organotypic rafts were 
studied by heat induced antigen retrieval methods (tris buffer and citrate buffer) 
followed by immunofluorescence detection. The intensities of staining (Q-score) were 
quantified as previous described (8).  
TCGA dataset analysis 
HNSCC samples processed for the TCGA resource (4) were utilised for in silico 
analyses/support of laboratory findings. Processed (level three) gene expression data 
for 277 HNSCC patients, 277 tumour and 44 matched normal tissue, was downloaded 
from Gene Expression Omnibus, GEO ascension number GSE62944 (25) and 
supporting clinical data from University of California Santa Cruz Cancer Browser 
(https://genome-cancer.ucsc.edu/proj/site/hgHeatmap/).  HPV Status was previously 
defined by the TCGA (5)  in these samples, as the presence of >1000 mapped RNA 
sequencing reads aligning to HPV viral genes E6 and E7 (5) and was obtained 
through cbioportal (http://www.cbioportal.org/). Gene expression data was log2(x+1) 
transformed before merging with clinical data. The resulting data matrix was used to 
plot expression of genes of interest between normal, HPV positive and negative. 
Patients were dichotomised into high/low expressing groups for survival analyses by 
receiver-operating characteristic analysis of the gene of interest against survival as 
previously described (26). Survival analyses were performed using the Kaplan-Meier 
estimate on a sub-cohort of 241 HPV negative patients with survival data and the log-
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rank test used to calculate univariate associations between genes of interest and 
survival. Only five year survival was considered and defined as the time, in months, 
from sample collection until death by any cause, with right censoring applied to 
patients lost to follow-up or with a survival time of greater than 60 months. These 
analyses were performed using R v.3.3.1. 
ChIP-seq and analysis of Public ChIP-seq datasets 
TP63 ChIP-seq data was generated from HFK-E6E7 expressing cells as previously 
described (12). Raw FASTQ data and those from our previously published ChIP-seq 
for p63 in primary HFKs (12) were re-analysed as follows:  Adapter sequences were 
removed and FASTQC conducted with trimgalore and resulting reads aligned to hg19 
with Bowtie 2 default settings (27). Reads filtered for blacklist regions with samtools 
were used as inputs for peak calling with MACS2 (28) comparing ChIP with input 
control and resultant SPMR normalised bedgraphs converted to bigwig format for 
visualisation using UCSC bedGraphToBigWig script. Relevant bigwig files from 
encode (29) were downloaded and visualised alongside p63. Integrative analysis of 
narrowpeak calls was conducted using custom workflows in Cistrome (30). 
Statistics 
   The statistics for lab experiments were performed by comparing the mean values by 
student’s t-test and one-way analysis of variance (ANOVA) followed by Dunnet’s 
post hoc analysis using IBM SPSS 20.0 software. The results were presented as 
mean±s.e.m. from five independent experiments and P<0.05 was considered to be 
significant in all the experiments.  For TCGA gene expression analysis, results were 
presented as  mean±s.e.m. and statistical significance defined as ***P<0.001, **P<0.01, 
and *P<0.05 when calculated by either Welch’s t-test (A) or ANOVA (C, D) when 
compared to the normal/controls. 
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Results 
Slug/SNAI2 is the predominant EMT-promoting gene expressed in HNSCC 
    To investigate de-regulation of EMT-promoting transcription factors in HNSCC, 
we first examined expression of EMT master regulatory transcription factors 
Twist/TWIST1, Snail/SNAI1 and Slug/SNAI2, in HNSCC patient samples in The 
Cancer Genome Atlas (TCGA) (HPV positive (n=36) and HPV negative (n=241)  (4). 
This revealed that expression of  SNAI1, SNAI2 and TWIST1 were significantly 
increased in both HPV positive and negative tumours compared to normal (Figure 
1A). Importantly, while signficant increases of both SNAI1 and TWIST1 were 
observed, the absolute expression levels of SNAI1/Snail and TWIST1  were 5-10 fold 
lower than Slug/SNAI2 as measured by FPKM (fragments per kilobase of exon per 
million fragments mapped) (Figure 1A), with SNAI1 and TWIST exhibiting more 
modest fold change in expression compared to normal than SNAI2/Slug (SNAI2 
2.02/3.70; SNAI1 1.40/1.59, TWIST1 1.51/1.89 in HPV+ve and HPV-ve tumours 
respectively) suggesting that Slug/SNAI2 is the predominantly expressed EMT-
regulating transcription factor activated in HNSCC. Further examination of 
expression levels and correlation of  SNAI1, SNAI2, TWIST1 and other EMT 
regulators ZEB1 and ZEB2 and markers Vimentin (VIM), E-Cadherin (CDH1), N-
Cadherin (CDH2)  and Fibronectin (FN1); revealed similarly modest expression of 
both ZEB1 and ZEB2, with only ZEB2 demonstrating significant upregulation (ZEB1 
1.09/1.16; ZEB2 1.36/1.33 in HPV+ve and HPV-ve tumours respectively.   
      In support of the prediction that Slug/SNAI2 is important for EMT, we observed 
significant increases in Slug/SNAI2 protein levels (as measured by indirect 
immunfluorescent staining) when comparing tumour versus adjacent normal in  full 
face sections of both HPV positive (n=5), and HPV negative (n=6) oropharyngeal 
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HNSCC (Figure 1B and C and Supplementary Figure S2A).  Interestingly, in 
agreement with recent studies in normal skin (31), only a few basal cells in normal 
regions stained positive for Slug/SNAI2,whereas, in contrast, intense nuclear 
localisation of Slug/SNAI2 was observed throughout both HPV positive and negative 
tumours (Figure 1B and C and Supplementary Figure S2A). In addition, the faint 
staining of Snail/SNAI1 and TWIST1 proteins in epithelial cells from normal and 
tumour sections suggested low protein expression in these cells compared to the 
adjacent stromal cells (Supplementary Figure S2A).  
     Further evaluation of  SNAI1, SNAI2, TWIST1, ZEB1 and ZEB2 protein and 
mRNA levels in our invasive HPV-E6/E7 expression model system (8,22,32), also 
indicates that Slug/SNAI2 is the predominant EMT-activating transcription factor 
expressed in E6/E7-HFK and normal matched keratinocyte controls, and is 
significantly up-regulated at both the mRNA and protein level in E6/E7-HFK (Figure 
1D and E and Supplementary Figure S2B).  Similar to TCGA patient analysis, while 
relative increases in both Twist/TWIST1 and Snail/SNAI1 mRNA expressions in 
E6/E7-HFK were also observed (Figure 1D), their levels were at the limit of detection 
by both RT-PCR and Western blot analysis (Figure 1D and Supplementary Figure 
S2B). Importantly, elevated Slug/SNAI2 coincided with a switch to spindle like 
morphology (Figure 1F), significant decrease in expression of both E-cadherin/CDH1 
mRNA and protein and  concomitant increase in Vimentin/VIM and Fibronectin/FN1 
(Figure 1D, E and Supplementary Figure S2B) as well  a loss of junctional E-
Cadherin staining (Figure 1G); suggesting that E6/E7 expressing cells exhibit an EMT 
phenotpye.  
 
 
Research. 
on May 10, 2018. © 2018 American Association for Cancerclincancerres.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on May 8, 2018; DOI: 10.1158/1078-0432.CCR-17-3775 
13 
 
Depletion of Slug attenuates EMT and mitigates invasion  
       To determine the functional contribution of Slug/SNAI2 in mediating EMT and 
invasion we used two independent siRNA molecules (24) to knockdown Slug/SNAI2 
expression in E6/E7-HFK (Figure 2A-C and Supplementary S3A). Depletion of 
Slug/SNAI2 resulted in a reversal of EMT as measured by increase in mRNA and 
protein expression of E-cadherin, concomitant reduction in the expression of vimentin 
(Figure 2A and C), reversion of spindle-like to cobble-stone morphology and 
concurrent increase in E-cadherin/CDH1 localisation at cell junctions (Figure 2C and 
Supplementary Figure S3A). Importantly, qualitative and quantitative analysis of 3D-
organotypic rafts established using E6/E7-HFK with confirmed knockdown of Slug 
expression by the more effective siRNA (mol-2) showed a significant reduction in 
number of  invasions (Figure 2D and E) and that these effects were independent of 
cell proliferation as measured by BrdU uptake (Supplementary Figure S3B and C), 
indicating that Slug/SNAI2 is necessary for both EMT and invasion in this model. 
 
SRC signalling axis modulates the expression of EMT markers 
       Western blot analysis revealed that Slug/SNAI2 depletion (Supplementary Figure 
S4A) did not affect SRC levels and activatory phosphorylation (Y416), which we have 
previously shown to be necessary and sufficient for invasion. We next evaluated 
whether Slug/SNAI2 was activated downstream of SRC and required for EMT and 
invasion. In support of this hypothesis both Slug/SNAI2 mRNA and protein 
expression were significantly decreased in 2D-culture upon transient siRNA mediated 
depletion of SRC expression with two independent siRNAs (Figure 3A and B).  
Moreover, a similar reduction  of  Slug/SNAI2 protein was observed upon inhibition 
of Src activity using the kinase inhibitor dasatanib, both in 2D-culture (Figure 3C) 
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and in treated organotypic raft cultures (Figure 3D), where we previously 
demonstrated the ability of dasatanib or SRC depletion to block invasion (8).  In 
support of a mechanistic role for EMT, both SRC depletion or inhibition were 
accompanied by a cognate decreased vimentin and increased E-cadherin expression 
(Figure 3A-C) and restoration of gross cellular morphology suggestive of a reversion 
of  EMT (Supplementary Figure S4B). Moreover, exogenous adenoviral expression of 
constitutively active Src (Src-531), which is sufficient to promote cell invasion (8), 
also upregulated the protein expression of Slug and vimentin, while suppressing E-
cadherin and inducing EMT morphology in non-invasive cells (Supplementary Figure 
S4C, D).   
Analysis of TCGA patient RNA-seq data revealed that SRC mRNA 
expression is significantly elevated in both HPV positive and negative HNSCC 
tumours compared to normal (Figure 3E). Importantly, dichotomising patients into 
high and low expressing groups (based on receiver operator curve (ROC) outcome 
based dichomisation of 5-year overall survival) (26), identified a significant 
association between high SRC expression (high=48, low=192) and worse outcome in 
HPV negative patients (Figure 3F).   
     Ascertaining impact of intratumoural expression of other EMT transcription 
factors (SNAI1/Snail, TWIST1, ZEB1 and ZEB2) and markers (CDH1, CDH2, VIM, 
FN1) on survival is challenging owing to the high level expression of EMT factors in 
stromal cells (Figure 1 B and Supplementary Figure S2 A).  Further analysis revealed 
high levels of correlation between all of these stromally derived markers (data not 
shown) and no coherent pattern of impact on outcome (Data not shown). 
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TP63 modulates the expression of SNAI2 
      Interestingly, a similar trend was observed for total TP63 expression (Figure 4A), 
where high TP63 levels were associated with worse outcome.  Since we have 
previously shown that TP63 is necessary to effect invasion in this model by regulating 
SRC-AKT-AP1 signalling (8), we next compared TP63-ChIP-seq in E6/E7-HFK with 
our previous TP63 ChIP-seq in primary HFKs (12) (Supplementary Figure S5A). 
Similar TP63 binding patterns were observed globally and specifically at the 
previously described SRC (Figure 4B) and MMP14 (not shown)  associated enhancer 
regions (8). Furthermore, we also identified direct TP63 binding to upstream enhancer 
and promoter of SNAI2 and upstream and within CDH1 loci (E-cadherin) (Figure 4B 
and Supplementary Figure S5B).  Importantly, siRNA mediated depletion of all TP63 
isoforms resulted in significant decreased Slug/SNAI2 mRNA and protein levels 
(Figure 4C and D). Significantly, depletion of Slug did not affect TP63 mRNA or 
mRNA splice-form or protein isoform expression (Supplementary Figure S6A and B) 
indicting that TP63 is required for  SRC dependent transcription of Slug/SNAI2 and 
EMT that is necessary for invasion.  
 
TP63γ isoform is necessary for the Src-Slug signalling, EMT and invasion  
  Since we and others have consistently observed differential and often 
opposing effects of expressing different TP63 isoforms on target gene expression and 
resulting phenotypes (11,33-35), we speculated that TP63 mediated activation of SRC 
and Slug/SNAI2 may be differentially affected by TP63 isoforms similar to our 
previous observations with regard to the role of ΔNp63γ isoform in affecting EMT in 
breast epithelial cells (13). To investigate this possibility, we first compared the 
effects of specifically depleting the α and β isoforms through targettiing their shared 
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3’UTR (UTR) (with a validated shRNA molecule that does not affect γ-isoforms) (9) 
with an shRNA targeting the DNA binding domain (DBD) and therefore depleting all 
TP63 isoforms (DBD); which we had previously reported to attenuate invasion in this 
model (8).  This analysis revealed that depletion of the α and β isoforms had little or 
no effect on number of invasions (Supplementary Figure S7A-C) suggesting that 
residual γ-isoforms are sufficient to maintain invasive capacity. These results were 
further supported by similar analysis with independent siRNAs, where total p63 
depletion (Pan molecule) was sufficient to significantly reduce the number of  
invasions (Figure 5A and B). In support of these results, mRNA or protein expression 
of Src, Slug/SNAI2, vimentin and Src activity were unaffected in UTR depleted cells 
grown in 2D on collagen I (Figure 5C-E), whereas in contrast, total TP63 knockdown 
depleted mRNA and protein expression of both Src and Slug (Figure 5D and E) with a 
concomitant increase in the protein levels of E-cadherin while suppressing vimentin 
(Figure 5D and E). Cumulatively, this suggests that the residual endogenous TP63γ 
isoform  sufficient to maintain the expression/activity of Src-Slug signalling axis, 
EMT and and invasive phenotype. 
 
ΔNp63γ is sufficient to induce Src-Slug axis, EMT and invasion 
We have previously shown that ΔN N-terminal variants are the dominant forms in 
both normal (9) and E6/E7 expressing HFKs (36) with endogenous TA isoforms 
below the limit of Western blotting and not normally detectable by RT-PCR (data not 
shown). Therefore, we next tested if expression of ΔNp63γ or indeed ΔNp63 or 
ΔNp63 alone, is sufficient to rescue EMT and invasion in E6/E7-HFK rendered non-
invasive through stable shRNA depletion of total TP63. To achieve this we compared 
the effects of adenoviral-mediated reintroduction of individual TP63 isoforms 
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rendered resistant to the shRNA into E6/E7-HFK cells (13). Growth of these 
reconstituted cells in organotypic cultures revealed that only re-expression of the 
ΔNp63γ isoform was capable of significantly inducing invasions (Figure 6A and B), 
whereas ΔNp63 had a modest repressive effect on residual invasion and ΔNp63 no 
significant impact. Importantly, ectopic expression of ΔNp63γ isoform in 
keratinocytes was sufficient to significantly upregulate mRNA levels of SRC and 
SNAI2, while suppressing CDH1 (E-cadherin) compared to its controls (GFP) (Figure 
6C), co-incident with upregulation of protein expression of Src, activated Src, Slug, 
activated AKT and vimentin and suppression of E-cadherin (Figure 6D and 
Supplementary Figure S7D). Together these results identify a potentially important 
novel oncogenic role of ΔNp63γ isoform in E6/E7-HFK, which is sufficient to 
induced Src activated EMT and invasion in squamous cells. 
 
 
 Discussion 
     Depletion of cellular epithelial markers with concurrent appearance of those of 
mesenchymal cells is an important switch required to enable morphological and 
mechanical changes necessary to underpin the invasive capacity of cancer cells. Here, 
we identify that expression of ΔNp63γ isoform as both necessary and sufficient to 
induce such a switch in E6/E7 transformed primary human keratinocytes to promote 
an EMT-like phenotype and invasion. This is mediated through direct transcriptional 
modulation and activation of Slug/SNAI2 and Src, the increased expression of which 
is observed along with TP63 in both HPV positive and negative HNSCC patients. In 
particular, increased SRC levels correlates with poor prognosis and represents a 
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potential clinically actionable event through inhibition of Src or downstream AKT 
activity. 
     Our previous studies demonstrated that E6/E7-HFK exhibited increased cell 
migration and invasion compared to normal HFK (8). In this study we focused on 
determining the importance of master transcriptional regulators of EMT namely 
SNAI1/Snail, SNAI2/Slug, TWIST1/Twist, given their importance for EMT required 
for cancer cell migration, invasion and ultimately metastasis. Our analyses revealed 
that Slug is the dominant EMT regulator increased in both our invasive E6/E7-HFK 
model and in patient samples, wherein both Snail and Twist are expressed at much 
lower levels a finding that is strongly supported by a recent landmark single cell study 
of HNSCC patient samples (37) which indicates that the majority of signal for EMT 
markers with the exception of SNAI2/Slug are stromally derived in HNSCC and is 
associated with a partial EMT.  Importantly, depletion of Slug is sufficient to reverse 
the increases in vimentin, decrease E-Cadherin, and change cells from a fibroblast-
like to an epithelial-like morphology and prevent invasion in 3D organotypic cultures, 
suggesting Slug is necessary for the invasive phenotype.  There is significant evidence 
in the literature to support the broader applicability of our findings with regard to the 
importance of SNAI2/Slug for HNSCC cell survival, migration, invasion, stemness 
and radioresistance (38-41).  Consistent with our hypothesis, the overexpression of 
Slug/SNAI2 and its increased transcriptional activity in normal human keratinocytes 
has been shown to induce a) transcriptional silencing of differentiation genes, b) 
dedifferentiation, c) EMT, d) wound healing and e) enhanced cell migration 
(31,42,43).  
     Moreover, our IHC studies in HPV +ve and -ve oropharyngeal HNSCC  are 
supported by findings by Wang et al., which indicated that elevated Slug/SNAI2 
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expression in HNSCC tumour cells in a cohort of 129 HNSCC correlated with poor 
prognosis (38). Since the expression or activities of components from TP63/Src 
signalling axis, remained unaffected by Slug/SNAI2 depletion it suggests that it is a 
downstream target of this signalling cascade. This is consistent with a recently 
published study which also identified Slug/SNAI2 as a direct p63 target in lung SCC 
and breast cancer cell lines (44).    
      Transcriptional and protein levels of TP63 isoforms are elevated in E6/E7-HFK 
and depletion of total TP63 isoforms has been previously shown to attenuate the cell 
invasion (8). However, in the current study stable knockdown of the TP63 α and β 
isoforms (UTR) in the invasive population had no significant impact in reducing the 
number of invasions. However, since total TP63 ablation depleted the expression of 
Src and reversed expression of EMT genes, it indicates that either TAp63γ or ΔNp63γ 
isoforms are responsible for promoting EMT and invasion. Our previous studies on 
normal breast cells have shown the role ΔNp63γ in promoting EMT phenotype and 
development of epithelial cancers (13). Since the ΔNp63 isoforms are more stable 
compared to the TAp63 isoforms due to the absence of structural features like the 
FWL motif which accelerates the TAp63 protein degradation (45,46), and since 
TAp63 levels are almost undetectable in HFK, we expressed ΔNp63 isoforms (α, β 
and γ) in a background where all TP63 isoforms were depleted by stable knockdown.  
Ectopic expression of the ΔNp63γ isoform only, induced invasion  concomitant with 
activation of both SRC/AKT signalling and Slug-mediated EMT .  
     In conclusion,  the ΔNp63γ isoform appears to be essential for mediating invasion 
by modulating the expression of Slug and by activating Src signalling. Specific 
inhibition of Src activity has a therapeutic potential alone or as recently suggested in 
combination with epidermal growth factor receptor and other receptor tyrosine kinase 
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inhibitors to protect against progression and relapse of HNSCC, which are problems 
in treating these cancers (47-49).  
 
Acknowledgement 
The authors thank Medical Research Council, UK grant G1001692 for funding this 
study. The patient samples used in this research were received from the Northern 
Ireland Biobank (NIB13-001) which has received funds from HSC Research and 
Development Division of the Public Health Agency in Northern Ireland and the 
Friends of the Cancer Centre.  ChIP-seq data generation in this study was supported 
by the FMHLS, Genomics Core Technology Unit, Queen’s University Belfast. 
 
Supplementary information accompanies the paper on the CCR website 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Research. 
on May 10, 2018. © 2018 American Association for Cancerclincancerres.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on May 8, 2018; DOI: 10.1158/1078-0432.CCR-17-3775 
21 
 
References 
 
1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of 
worldwide burden of cancer in 2008: GLOBOCAN 2008. International 
Journal of Cancer 2010;127(12):2893-917 doi 10.1002/ijc.25516. 
2. Goon PKC, Stanley MA, Ebmeyer J, Steinstraesser L, Upile T, Jerjes W, et al. 
HPV & head and neck cancer: a descriptive update. Head & Neck Oncology 
2009;1 doi 10.1186/1758-3284-1-36. 
3. Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, et al. 
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification 
within and across Tissues of Origin. Cell 2014;158(4):929-44 doi 
10.1016/j.cell.2014.06.049. 
4. Lawrence MS, Sougnez C, Lichtenstein L, Cibulskisl K, Lander E, Gabriel 
SB, et al. Comprehensive genomic characterization of head and neck 
squamous cell carcinomas. Nature 2015;517(7536):576-82 doi 
10.1038/nature14129. 
5. Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidransky D. A new human 
p53 homologue. Nature Medicine 1998;4(7):747-8 doi 10.1038/nm0798-747. 
6. McDade SS, McCance DJ. The role of p63 in epidermal morphogenesis and 
neoplasia. Biochemical Society Transactions 2010;38:223-8 doi 
10.1042/bst0380223. 
7. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW. p63 
mediates survival in squamous cell carcinoma by suppression of p73-
dependent apoptosis. Cancer Cell 2006;9(1):45-56 doi 
10.1016/j.ccr.2005.12.013. 
8. Srivastava K, Pickard A, McDade S, McCance DJ. p63 drives invasion in 
keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK 
signalling. Oncotarget 2015;Epub, DOI:10.18632. 
9. McDade SS, Patel D, McCance DJ. p63 maintains keratinocyte proliferative 
capacity through regulation of Skp2-p130 levels. Journal of Cell Science 
2011;124(10):1635-43 doi 10.1242/jcs.084723. 
10. Ramsey MR, Wilson C, Ory B, Rothenberg SM, Faquin W, Mills AA, et al. 
FGFR2 signaling underlies p63 oncogenic function in squamous cell 
carcinoma. Journal of Clinical Investigation 2013;123(8):3525-38 doi 
10.1172/jci68899. 
11. McDade SS, Henry AE, Pivato GP, Kozarewa I, Mitsopoulos C, Fenwick K, 
et al. Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-
regulators of epidermal differentiation. Nucleic Acids Research 
2012;40(15):7190-206 doi 10.1093/nar/gks389. 
12. McDade SS, Patel D, Moran M, Campbell J, Fenwick K, Kozarewa I, et al. 
Genome-wide characterization reveals complex interplay between TP53 and 
TP63 in response to genotoxic stress. Nucleic Acids Research 
2014;42(10):6270-85 doi 10.1093/nar/gku299. 
13. Lindsay J, McDade SS, Pickard A, McCloskey KD, McCance DJ. Role of 
Delta Np63 gamma in Epithelial to Mesenchymal Transition. Journal of 
Biological Chemistry 2011;286(5):3915-24 doi 10.1074/jbc.M110.162511. 
14. Zhang Y, Yan W, Chen X. P63 regulates tubular formation via epithelial-to-
mesenchymal transition. Oncogene 2014;33(12):1548-57 doi 
10.1038/onc.2013.101. 
Research. 
on May 10, 2018. © 2018 American Association for Cancerclincancerres.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on May 8, 2018; DOI: 10.1158/1078-0432.CCR-17-3775 
22 
 
15. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-
cadherin promotes metastasis via multiple downstream transcriptional 
pathways. Cancer Research 2008;68(10):3645-54 doi 10.1158/0008-5472.can-
07-2938. 
16. Hajra KM, Chen DYS, Fearon ER. The SLUG zinc-finger protein represses E-
cadherin in breast cancer. Cancer Research 2002;62(6):1613-8. 
17. Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, et al. ER alpha 
signaling through slug regulates E-cadherin and EMT. Oncogene 
2010;29(10):1451-62 doi 10.1038/onc.2009.433. 
18. Rodrigues IS, Lavorato-Rocha AM, Maia BdM, Stiepcich MMA, de Carvalho 
FM, Baiocchi G, et al. Epithelial-mesenchymal transition-like events in vulvar 
cancer and its relation with HPV. British Journal of Cancer 2013;109(1):184-
94 doi 10.1038/bjc.2013.273. 
19. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for 
cancer therapy. Cellular and Molecular Life Sciences 2011;68(18):3033-46 
doi 10.1007/s00018-011-0735-1. 
20. Fincham VJ, Frame MC. The catalytic activity of Src is dispensable for 
translocation to focal adhesions but controls the turnover of these structures 
during cell motility. Embo Journal 1998;17(1):81-92 doi 
10.1093/emboj/17.1.81. 
21. Bianchi-Smiraglia A, Paesante S, Bakin AV. Integrin beta 5 contributes to the 
tumorigenic potential of breast cancer cells through the Src-FAK and MEK-
ERK signaling pathways. Oncogene 2013;32(25):3049-58 doi 
10.1038/onc.2012.320. 
22. Pickard A, Cichon A-C, Barry A, Kieran D, Patel D, Hamilton P, et al. 
Inactivation of Rb in stromal fibroblasts promotes epithelial cell invasion. 
EMBO J 2012;31(14):3092-103 doi 10.1038/emboj.2012.153. 
23. Lowenstein PR, Enquist LW. Protocols for Gene Transfer in Neuroscience: 
Towards Gene Therapy of Neurological Disorders. Chichester, NY: Wiley and 
Sons.; 1996. 
24. Mittal MK, Singh K, Misra S, Chaudhuri G. SLUG-induced Elevation of D1 
Cyclin in Breast Cancer Cells through the Inhibition of Its Ubiquitination. 
Journal of Biological Chemistry 2011;286(1):469-79 doi 
10.1074/jbc.M110.164384. 
25. Rahman M, Jackson LK, Johnson WE, Li DY, Bild AH, Piccolo SR. 
Alternative preprocessing of RNA-Sequencing data in The Cancer Genome 
Atlas leads to improved analysis results. Bioinformatics 2015;31(22):3666-72 
doi 10.1093/bioinformatics/btv377. 
26. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored 
survival data and a diagnostic marker. Biometrics 2000;56(2):337-44 doi 
10.1111/j.0006-341X.2000.00337.x. 
27. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nature 
Methods 2012;9(4):357-U54 doi 10.1038/nmeth.1923. 
28. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. 
Model-based Analysis of ChIP-Seq (MACS). Genome Biology 2008;9(9) doi 
10.1186/gb-2008-9-9-r137. 
29. Myers RM, Stamatoyannopoulos J, Snyder M, Dunham I, Hardison RC, 
Bernstein BE, et al. A User's Guide to the Encyclopedia of DNA Elements 
(ENCODE). Plos Biology 2011;9(4) doi 10.1371/journal.pbio.1001046. 
Research. 
on May 10, 2018. © 2018 American Association for Cancerclincancerres.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on May 8, 2018; DOI: 10.1158/1078-0432.CCR-17-3775 
23 
 
30. Liu T, Ortiz JA, Taing L, Meyer CA, Lee B, Zhang Y, et al. Cistrome: an 
integrative platform for transcriptional regulation studies. Genome Biology 
2011;12(8) doi 10.1186/gb-2011-12-8-r83. 
31. Mistry DS, Chen Y, Wang Y, Zhang K, Sen GL. SNAI2 Controls the 
Undifferentiated State of Human Epidermal Progenitor Cells. Stem Cells 
2014;32(12):3209-18 doi 10.1002/stem.1809. 
32. Cichon A-C, Pickard A, McDade SS, Sharpe DJ, Moran M, James JA, et al. 
AKT in stromal fibroblasts controls invasion of epithelial cells. Oncotarget 
2013;4(7):1103-16. 
33. Gu X, Coates PJ, Boldrup L, Nylander K. p63 contributes to cell invasion and 
migration in squamous cell carcinoma of the head and neck. Cancer Letters 
2008;263(1):26-34 doi 10.1016/j.canlet.2007.12.011. 
34. Candi E, Rufini A, Terrinoni A, Dinsdale D, Ranalli M, Paradisi A, et al. 
Differential roles of p63 isoforms in epidermal development: selective genetic 
complementation in p63 null mice. Cell Death and Differentiation 
2006;13(6):1037-47 doi 10.1038/sj.cdd.4401926. 
35. Boldrup L, Coates PJ, Gu XL, Nylander K. Delta Np63 isoforms differentially 
regulate gene expression in squamous cell carcinoma: identification of Cox-2 
as a novel p63 target. Journal of Pathology 2009;218(4):428-36 doi 
10.1002/path.2560. 
36. McKenna DJ, McDade SS, Patel D, McCance DJ. MicroRNA 203 Expression 
in Keratinocytes Is Dependent on Regulation of p53 Levels by E6. Journal of 
Virology 2010;84(20):10644-52 doi 10.1128/jvi.00703-10. 
37. Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, et al. Single-
Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in 
Head and Neck Cancer. Cell 2017;171(7):1611-+ doi 
10.1016/j.cell.2017.10.044. 
38. Wang C, Liu XQ, Huang HZ, Ma HB, Cai WX, Hou JS, et al. Deregulation of 
Snai2 is associated with metastasis and poor prognosis in tongue squamous 
cell carcinoma. International Journal of Cancer 2012;130(10):2249-58 doi 
10.1002/ijc.26226. 
39. Zhao TT, He QT, Liu ZH, Ding XQ, Zhou XF, Wang AX. Angiotensin II type 
2 receptor-interacting protein 3a suppresses proliferation, migration and 
invasion in tongue squamous cell carcinoma via the extracellular signal-
regulated kinase-Snai2 pathway. Oncology Letters 2016;11(1):340-4 doi 
10.3892/ol.2015.3898. 
40. Jiang FF, Zhou LJ, Wei CB, Zhao W, Yu DS. Slug inhibition increases 
radiosensitivity of oral squamous cell carcinoma cells by upregulating PUMA. 
International Journal of Oncology 2016;49(2):709-19 doi 
10.3892/ijo.2016.3570. 
41. Chung MK, Jung YH, Lee JK, Cho SY, Murillo-Sauca O, Uppaluri R, et al. 
CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck 
Squamous Cell Carcinoma through the Upregulation of Slug. Clinical Cancer 
Research 2018;24(3):674-83 doi 10.1158/1078-0432.ccr-17-0866. 
42. Savagner P, Kusewitt DF, Carver EA, Magnino F, Choi C, Gridley T, et al. 
Developmental transcription factor slug is required for effective re-
epithelialization by adult keratinocytes. Journal of Cellular Physiology 
2005;202(3):858-66 doi 10.1002/jcp.20188. 
43. Hudson LG, Newkirk KM, Chandler HL, Choi C, Fossey SL, Parent AE, et al. 
Cutaneous wound reepithelialization is compromised in mice lacking 
Research. 
on May 10, 2018. © 2018 American Association for Cancerclincancerres.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on May 8, 2018; DOI: 10.1158/1078-0432.CCR-17-3775 
24 
 
functional Slug (Snai2). Journal of Dermatological Science 2009;56(1):19-26 
doi 10.1016/j.jdermsci.2009.06.009. 
44. Dang TT, Westcott JM, Maine EA, Kanchwala M, Xing C, Pearson GW. 
Delta Np63 alpha induces the expression of FAT2 and Slug to promote tumor 
invasion. Oncotarget 2016;7(19):28592-611 doi 10.18632/oncotarget.8696. 
45. Serber Z, Lai HC, Yang A, Ou HD, Sigal MS, Kelly AE, et al. A C-terminal 
inhibitory domain controls the activity of p63 by an intramolecular 
mechanism. Molecular and Cellular Biology 2002;22(24):8601-11 doi 
10.1128/mcb.22.24.8601-8601.2002. 
46. Okada Y, Osada M, Kurata S, Sato S, Aisaki K, Kageyama Y, et al. p53 gene 
family p51 (p63)-encoded, secondary transactivator p51 B(TAp63 alpha) 
occurs without forming an immunoprecipitable complex with MDM2, but 
responds to genotoxic stress by accumulation. Experimental Cell Research 
2002;276(2):194-200 doi 10.1006/excr.2002.5535. 
47. Stabile LP, He GQ, Lui VWY, Henry C, Gubish CT, Joyce S, et al. c-Src 
Activation Mediates Erlotinib Resistance in Head and Neck Cancer by 
Stimulating c-Met. Clinical Cancer Research 2013;19(2):380-92 doi 
10.1158/1078-0432.ccr-12-1555. 
48. Egloff AM, Grandis JR. Targeting epidermal growth factor receptor and Src 
pathways in head and neck cancer. Seminars in Oncology 2008;35(3):286-97 
doi 10.1053/j.seminoncol.2008.03.008. 
49. Koppikar P, Choi SH, Egloff AM, Cai Q, Suzuki S, Freilino M, et al. 
Combined inhibition of c-Src and epidermal growth factor receptor abrogates 
growth and invasion of head and neck squamous cell carcinoma. Clinical 
Cancer Research 2008;14(13):4284-91 doi 10.1158/1078-0432.ccr-07-5226. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Research. 
on May 10, 2018. © 2018 American Association for Cancerclincancerres.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on May 8, 2018; DOI: 10.1158/1078-0432.CCR-17-3775 
25 
 
Titles and legends to figures 
 
Figure 1. (A) Comparison of mRNA expression of SNAI1, SNAI2 and TWIST1 
mRNA levels in normal tissue (n=44), human papilloma virus (HPV) +ve (n=36) and 
HPV-ve (n=241) HNSCC in the TCGA RNA-seq cohort.  (B, C) 
Immunofluorescence detection and quantification (Q-score) of Slug protein in normal 
epithelium and tumour areas from HPV+ve and HPV-ve oropharyngeal HNSCC. N=5 
HPV(+ve) and 6 HPV(-ve) tumour sections. (D) Fold difference in mRNA expression 
of TWIST1, SNAI1, SNAI2, VIM and CDH1 genes; and (E) protein expression of E-
cadherin, Slug, vimentin and β-actin in control (pBabe-HFK) and E6/E7-HFK, 
respectively. (F) Phase contrast images indicating normal cobble stone (green asterix) 
and elongated spindle-like EMT (red arrows) morphology. (G) Immunofluorescence 
visualisation of E-cadherin (white arrows) and nuclei (DAPI). Scale bars represented 
as 20μm and 100μm. Data represented as mean±s.e.m. and statistical significance 
defined as ***P<0.001, **P<0.01, and *P<0.05 when calculated by either Welch’s t-test 
(A) or a one-way analysis of variance (C, D) when compared to the normal/controls. 
 
Figure 2. Depletion of Slug expression restores normal phenotype and attenuates cell 
invasion. (A) Fold difference in mRNA expression of SNAI2, VIM and CDH1 genes 
in Scram siRNA (control) and Slug siRNA mol-1 and mol-2 transfected cells; (B) 
phase contrast images indicating EMT (red arrows) and normal (green asterick) 
morphology and immunofluorescence visualisation of E-cadherin (white arrows), 
Slug and nuclei (DAPI) in control (scram) and Slug (mol-2) depleted E6/E7-HFK, 
respectively. (C) Protein expressions of Slug, vimentin, E-cadherin, and β-actin in the 
same cells as (A); (D) H&E staining showing invasions (arrows) on the 3D-
organotypic rafts established with control and Slug (mol-2) depleted E6/E7-HFK; and 
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(E) relative number of invasive incidents across these rafts per cm. Scale bars 
represented as 20μm and 100μm. N=5 independent experiments. Data represented as 
mean±s.e.m. and statistical significance calculated by Student’s t-test with *P<0.05 
compared to the control, **P<0.01 compared to the control. 
 
Figure 3. Depletion of Src expression alleviates EMT. (A) Fold difference in mRNA 
levels and/or (B) protein expression of Src, Slug, vimentin, E-cadherin and β-actin in 
Src (siRNA Src 1 and 2) depleted cells; (C) Protein expression of Src-pY416, total Src, 
Slug, vimentin, E-cadherin and β-actin in E6/E7-HFK treated in the absence and 
presence of specific Src inhibitor (dasatinib;10, 50 nM). (D) Immunofluorescence 
visualisation of Slug (red) and nuclei (DAPI) on rafts established with E6/E7-HFK 
and treated in the absence and presence of dasatinib (50 nM). Arrows indicate the 
invasive incidents in vehicle (control) rafts. High SRC expression correlates to poor 
survival. (E) Comparison of mRNA expression of SRC from normal tissue (n=44), 
human papilloma virus (HPV)+ve (n=36) and HPV-ve (n=241) HNSCC in the TCGA 
RNA-seq cohort.  (F) Kaplan-Meier plots of 5-year overall survival receiver operator 
curve (ROC) outcome based stratification of low and high mRNA levels of SRC in 
the above mentioned dataset. Scale bars represented as 100μm. N=3 independent 
experiments. Data represented as mean±s.e.m. and statistical significance defined as 
***P<0.001, **P<0.01, and *P<0.05 when calculated by either a one-way analysis of 
variance (A) or Welch’s t-test (E) when compared to the control/normals. 
 
Figure 4. TP63 modulates SNAI2 expression. (A) Kaplan-Meier plots of 5-year 
overall survival receiver operator curve (ROC) outcome based stratification of low 
and high mRNA levels of TP63 in the in the TCGA HNSCC HPV –ve cohort of 241 
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patients. (B)  Visualisation of E6/E7 and normal HFK TP63 ChIP-seq tracks around 
SRC and SNAI2 loci annotated with Encode histone modification data from normal 
human epidermal keratinocytes (NHEK) (Myers et al, 2011). (C, D) Relative mRNA 
and protein expressions of TP63 and SNAI2 after transient knockdown of total TP63 
in E6/E7-HFK. Cells transfected with scram siRNA molecule were treated as the 
control. N=3 independent experiments. Data represented as mean±s.e.m. and 
statistical significance calculated by Student’s t-test with *P<0.05 and **P<0.01 
compared to the controls. 
Figure 5. Depetion of different isoforms of TP63 attenuates EMT. (A) H&E staining 
showing invasive incidents (arrows) on 3D-organotypic rafts established with E6/E7-
HFK with  transient TP63  knockdown by UTR (TP63α, β) and Pan (total TP63) 
siRNA molecules; and (B) quantification of the number of invasive incidents across 
the rafts per cm established with these cells. (C, D) Relative mRNA expressions of 
TP63α, β, γ isoforms, SNAI2 and  SRC; and (E) protein expressions of total p63, total 
Src, Src-pY416, Slug, E-cadherin, vimentin and β-actin after transient knockdown with 
control (Scram), UTR p63 and Pan p63 molecules in E6/E7-HFK. Scale bars 
represented as 100μm. N=3 independent experiments. Data represented as 
mean±s.e.m. and statistical significance calculated by One-way analysis of variance 
with *P<0.05 and **P<0.01 compared to the Scram controls. 
Figure 6. TP63γ upregulation is sufficient for EMT. (A) H&E staining showing 
invasion (arrows) on 3D-organotypic rafts established after adenovirus-mediated 
introduction of GFP (control), ΔNp63α, β and γ isoforms in the E6/E7-HFK with 
stable total TP63 (DBD) depletion; and (B) quantification of number of invasive 
incidents across the rafts per cm established with these cells. (C) Relative mRNA 
levels of TP63γ, SRC, SNAI2 and CDH1 gene; and (D) protein expression of HA 
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(measure of transfected ΔNp63γ), total p63, total Src, Src-pY416, Slug, E-cadherin, 
vimentin, AKT-pS473, total AKT and β-actin in keratinocytes after adenovirus-
mediated expression of GFP and ΔNp63γ isoform. Scale bar represented as 100μm. 
N=3 independent experiments. Data represented as mean±s.e.m. and statistical 
significance calculated by One-way analysis of variance and Student’s t-test with 
*P<0.05, **P<0.01 and ***P<0.001 compared to GFP.  
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